Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Golden Sun Gsun Stock Rebounding Price At 0.48 Down 18.47 20260402 Is Liberty Lila Stock Breaking Support Price At 8.27 Down 0.72 20260410 Is Momentum Building In Lakeland Lkfn Stock Price At 60.49 Down 0.64 20260413 Daily Market Overview S And P 500 Nasdaq Edge Higher Dow Logs Mild Drop 20260408 1 Is Veea Veea Stock Cheap At Current Price Price At 0.63 Up 7.71 20260413 MGRB Affiliated exceeds expectations with 823 EPS signaling resilience in asset management operations What Nano NNE is doing to stay ahead Bullish Momentum 20260508 How Virtus NIE earnings power stacks up historically NIE Q3 Earnings Virtus Income Strategy Amid Convertible Market Challenges Galata LATA Stock Risk Reward Ratio 020 20260418 Is United PRKS stock worth a closer look 297 20260420 Bioventus BVS Stock Volume Volatility Nudges Up 20260422 Maase Inc MAAS Competitive Advantages Maase Inc posts huge revenue steep negative EPS NGEN NervGen posts narrow Q3 beat as clinical pipeline advances CEO reaffirms confidence in nerve repair therapy Perimeter PRM Stock Why Short Sellers Target It Extends Gains 20260420 How Quantum Corporation QMCO competitive position is evolving Bearish Sentiment 20260508 Dow Inc DOW Strong Buy Rating Affirmed Amid Unprecedented Petrochemical Supply Dislocation Tailwinds Charles Schwab Corporation SCHW Releases New Research Detailing Optimal Cryptocurrency Portfolio Allocation Guidelines What Impact BioMedical IBO disclosed about cash conversion IBO Recent Quarter Earnings Impact BioMedical shares core pipeline updates LNKB LINKBANCORP posts steep Q4 2025 EPS miss against estimates shares remain unchanged in daily trading Luang Prabang Tourism Gains Momentum as Laos Eyes Economic Recovery Through Cultural Heritage National NESR Q1 2026 Earnings Surprise EPS 026 Up Significant Genesco GCO Stock Today Rallies 231 Resistance at 3440 20260515 Yatsen YSG Q4 2025 Earnings Revenue NA Matching Views Seizure of Floating Armoury Vessel by Iran Raises Maritime Security Concerns in Gulf of Oman Undervalued Japanese Companies Brace for Surge in Foreign Takeover Interest IZEA Worldwide IZEA Climbs 131 Resistance at 407 in Focus 20260518 VirnetX Holding VHC Reports Q2 2025 Results EPS 099 Meets Consensus Tesla Cybertruck Incident Raises Questions Over Wade Mode Feature After Driver Arrested in Texas Lake Amesite Stock Surges 150 Following Enterprise Deal Announcement Soluna Holdings SLNH Q4 2025 Earnings Soft Quarter Raises Questions Star Health Launches Value Plus Plan Premiums Nearly 20 Lower as Insurer Marks 20Year Milestone T1 Energy Surges 42 Amid Analyst Optimism and ShortSeller Concerns CVS Health CVS Receives 8 Price Target Increase from Mizuho Analysts Billionaire Philippe Laffonts Coatue Management Makes Major ASML Bet as UBS Names It Europes Top Chip Stock Divis Laboratories Q4 Results Net Profit Rises 13 to Rs 751 Crore Revenue Up 10 Company Declares Rs 30 Dividend Nutriband NTRB Q1 2026 Earnings Massive EPS Beat Drives Stock Surge COSO Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction MOB Q4 2025 Earnings Significant EPS Miss Despite Strong Stock Rally LGI Homes Q1 2026 Earnings Shock EPS Beat Signals Strong Operational Momentum NVGS Q1 2026 Earnings Strong EPS Beat Amidst Underwhelming Market Response Lifecore Biomedical LFCR Declines 26 Testing Key Support at 456 CG Oncology CGON Retreats From Highs as Support Levels Are Tested Willis Lease Finance Corp WLFC Gains 178 as Aerospace Leasing Momentum Strengthens PRGO Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction CRH Q1 2026 Earnings NarrowerthanExpected Loss Amid Seasonal Headwinds CNI Q1 2026 Earnings Earnings Beat Driven by Operational Efficiency as Revenue Data Unavailable AURA Q1 2026 Earnings EPS Misses Estimates Stock Rises 24 on PreClinical Progress Erdoan Visits Astana as Turkey and Kazakhstan Target 13 Billion in Bilateral Trade Progress Software Corporation PRGS Q1 2026 Earnings EPS Slightly Beats Estimates Stock Edges Lower Trevi Therapeutics Q1 2026 Earnings Narrowing Losses but Trial Failures Weigh on Sentiment